ストックスクリーナーアプリを入手
749.06
0.26%
-2.3869
Lilly Eli Co (LLY) 最新ニュース
Eli Lilly extends Purdue alliance; EMA investigates Valneva shot - BioPharma Dive
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités - GlobeNewswire Inc.
Eli Lilly, Purdue to expand partnership with $250 million investment - CBS 4
Lilly to invest up to $250M in broadened alliance with Purdue University - Inside INdiana Business
Eli Lilly outlines support for Trump’s plans to ‘repatriate’ supply chains back to the US - Business Post
Eli Lilly & Co. (LLY) to expand Purdue University collaboration with up to a $250M investment to accelerate pharmaceutical innovation - StreetInsider
Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation - Stock Titan
Rx Rundown: Eli Lilly, Teva, Vivo Capital and more - Medical Marketing and Media
Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment - Endpoints News
Eli Lilly, Novo Nordisk report strong earnings as GLP-1 race heats up - Healthcare Brew
Eli Lilly and Company (LLY) Announces Results of 2025 Annual Sha - GuruFocus
Eli Lilly & Co Shareholders Vote on Key Issues - TipRanks
Eli Lilly (NYSE:LLY) Announces Executive Changes To Drive Global Growth And Pipeline Advancement - simplywall.st
Top Stock Movers Now: AB InBev, Molson Coors, Eli Lilly, and More - MSN
Lilly shuffles roles amid growth in U.S. investment, diabetes and obesity treatments - Inside INdiana Business
Eli Lilly falls, Arm reacts to chip curbs, D-Wave skyrockets - Yahoo Finance
Palantir, Eli Lilly lead Thursday’s market cap stock movers By Investing.com - Investing.com Canada
FDA, Lilly Score Win in Weight Loss Drug Shortage Decision (1) - Bloomberg Law News
Eli Lilly (LLY) Restructures Leadership to Propel U.S. Growth - GuruFocus
Are Wall Street Analysts Bullish On Eli Lilly Stock? - Barchart.com
Eli Lilly shifts executive roles to spur growth - Investing.com
Lilly names new executives in leadership transition (LLY:NYSE) - Seeking Alpha
Lilly announces transitions in executive leadership | Eli Lilly and Company - Eli Lilly and Company
Eli Lilly & Co. (LLY) Announces Leaderhsip Changes - StreetInsider
Lilly announces transitions in executive leadership - Stock Titan
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued? - Morningstar
Down Nearly 20%: Should You Buy the Dip on Eli Lilly? - MSN
'We are all richer for having had him in our lives': Patrick Holden dies after 500 Festival run - IndyStar
FDA Gets Win In Eli Lilly Weight Loss Drug Shortage Fight - Law360
US judge sides with FDA's removal of Lilly's weight loss drug from shortage list - Reuters
Judge Upholds FDA Decision Ending Zepbound Shortage, Favoring Eli Lilly (LLY) - GuruFocus
Lilly benefits as judge upholds FDA removing Zepbound from shortages list - Seeking Alpha
Eli Lilly and Company (LLY): A Bull Case Theory - MSN
Lilly chief scientist talks drugmaker’s new $4.5B campus, recruiting and innovation - Indianapolis Business Journal
Jim Cramer Says Eli Lilly and Company (LLY) CEO David Ricks Is ‘Very Conservative’ - Yahoo Finance
Construction begins on $4.5 billion Eli Lilly facility in Lebanon - WFYI
Eli Lilly & Co. (LLY) option IV flat - StreetInsider
'A completely new kind of facility' | Lilly breaks ground on new medicine foundry in Lebanon - WTHR
Lilly breaks ground on $4.5B foundry campus in Lebanon’s LEAP District - Indianapolis Business Journal
Lilly breaks ground on $4.5 billion R&D facility - WISH-TV
Governor breaks ground on $4.5 billion Lilly Medicine Foundry in Lebanon - reporter.net
Eli Lilly Stock Is Sliding Tuesday: What's Going On? - Benzinga
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped - The Motley Fool
Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership? - Nasdaq
Eli Lilly (LLY) Raises Dividend by 15%, Maintains Shareholder Payout for 55th Consecutive Year - TipRanks
Eli Lilly Stock Plunges: LLY Shares Dive Nearly 3% in Morning Trading - paginasiete.bo
Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip? - The Motley Fool
Eli Lilly (LLY) Partners with Alchemab on ALS Drug Development - GuruFocus
ELI LILLY AND COMPANY (LLY) - MSN
Lilly to Break Ground on $4.5 Billion Medicine Foundry in Lebanon - WIBC
Alchemab Therapeutics signs landmark $415m licensing agreement for ATLX-1282 with Eli Lilly and Company - PrimePublishers.com
Lilly to break ground on $4.5 billion medicine foundry in Lebanon - WISH-TV
Eli Lilly (LLY) Maintains Quarterly Dividend at $1.50 Per Share - GuruFocus
Eli Lilly announces $1.50 Q2 dividend per share By Investing.com - Investing.com India
Eli Lilly announces $1.50 Q2 dividend per share - Investing.com
Lilly declares second-quarter 2025 dividend - Quantisnow
LLY stock news: Eli Lilly Declares $1.50 Quarterly Dividend - paginasiete.bo
Lilly declares second-quarter 2025 dividend | Eli Lilly and Company - Eli Lilly and Company
Eli Lilly & Co. (LLY) Declares $1.50 Quarterly Dividend; 0.7% Yield - StreetInsider
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know - Yahoo Finance
Eli Lilly’s Strategic Adjustments and Growth Prospects Reinforce Buy Rating Despite Setbacks - TipRanks
Eli Lilly First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? - AOL.com
This pill could forever change how people lose weight3 May 2025Time Magazine EuropeReadly | All magazines - Readly | All magazines - one magazine app subscription
0.19%
0.96%
大文字化:
|
ボリューム (24 時間):